Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FXB11
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $56,959
Award facts
- Contract value 100% obligated
- $56,958.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Dupixent 300 mg/2 ml pen injections with a ceiling value of $56,958.95. This firm fixed price delivery order, which must be completed by August 28, 2025, is issued under a larger Indefinite Delivery Contract (IDC) vehicle—the DLA Troop Support Medical prime vendor contract designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through the DLA Medical Supply Chain. The SPE2DX prime vendor contract functions as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a comprehensive range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Dupixent, a specialty medication for treating atopic dermatitis and other inflammatory conditions, falls within the company's portfolio of brand-name pharmaceuticals regularly delivered through DLA contract vehicles to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FXB11?
SPE2DB25FXB11 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FXB11 worth?
The government has obligated $56,959 on SPE2DB25FXB11.
Is contract SPE2DB25FXB11 an order under another contract?
Yes. SPE2DB25FXB11 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FXB11 competed?
The extent of competition for SPE2DB25FXB11 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award